Article Text

Download PDFPDF
Attenuation of an amino-terminal premature stop codon mutation in the ATRX gene by an alternative mode of translational initiation
  1. M T Howard1,
  2. N Malik2,
  3. C B Anderson1,
  4. J L A Voskuil2,
  5. J F Atkins1,
  6. R J Gibbons2
  1. 1Department of Human Genetics, University of Utah, Salt Lake City, UT 84112-5330, USA
  2. 2MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, OX3 9DS, UK
  1. Correspondence to:
 Dr Richard Gibbons
 MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, OX3 9DS, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Nonsense mutations located in the 5′ end of the coding sequence of a gene are commonly considered to be null alleles. Not only do such mutations result in the production of a truncated and usually inactive protein product, but premature stop codon mutations that occur upstream of the last exon–exon junction are also known to activate nonsense mediated decay (NMD) which results in the specific degradation of the affected mRNA.1,2 However, several mechanisms may allow either fully or partially functional protein to be produced from alleles containing a premature stop codon mutation and this phenomenon may lead to considerable amelioration of the resulting phenotype.

First, translational decoding (miscoding) of the stop codon as a sense codon, which can occur naturally due to the context of the stop codon,3 may result in low level “leaky” expression of full length protein. Although no examples of stop codon readthrough leading to disease amelioration have been clearly documented in humans, this mechanism has been implied for several premature stop codons, most notably for a premature stop codon mutation in the cystic fibrosis transmembrane conductance regulator gene (MIM 602421) leading to mild pulmonary presentation.4,5 In this case, the equivalent mutation in a yeast gene, Ste6, has been shown to be suppressed at levels as high as 10%.3 Second, an internally truncated form of the protein may be expressed due to altered processing of the mRNA in which the stop codon containing exon (and sometimes adjacent exons) are removed from the mature mRNA.6 A correlation between exon skipping and suppression of disease symptoms has been documented in several cases of Becker muscular dystrophy (MIM 300376), a milder form of Duchenne muscular dystrophy.7,8 Third, protein expression in some genes can be rescued by translational initiation at internal start …

View Full Text


  • This work was supported by MRC (RG, NM, JV) and NIH GM48152 (JFA) and the Muscular Dystrophy Association (JFA and MTH).

  • Conflict of interest: none declared.